185 related articles for article (PubMed ID: 37271531)
1. [Recent topics in the pathophysiology and treatment of immune thrombocytopenic purpura].
Kashiwagi H
Rinsho Ketsueki; 2023; 64(5):397-405. PubMed ID: 37271531
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib.
Cooper N; Ghanima W; Hill QA; Nicolson PL; Markovtsov V; Kessler C
Platelets; 2023 Dec; 34(1):2131751. PubMed ID: 36331249
[TBL] [Abstract][Full Text] [Related]
3. Fostamatinib for persistent/chronic adult immune thrombocytopenia.
Newland A; Lee EJ; McDonald V; Bussel JB
Immunotherapy; 2018 Jan; 10(1):9-25. PubMed ID: 28967793
[TBL] [Abstract][Full Text] [Related]
4. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
[TBL] [Abstract][Full Text] [Related]
5. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.
Bussel J; Arnold DM; Grossbard E; Mayer J; Treliński J; Homenda W; Hellmann A; Windyga J; Sivcheva L; Khalafallah AA; Zaja F; Cooper N; Markovtsov V; Zayed H; Duliege AM
Am J Hematol; 2018 Jul; 93(7):921-930. PubMed ID: 29696684
[TBL] [Abstract][Full Text] [Related]
6. Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP).
Lee EJ; Izak M; Bussel JB
Br J Haematol; 2020 Apr; 189(2):379-382. PubMed ID: 31900937
[TBL] [Abstract][Full Text] [Related]
7. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
Zheng SS; Ahmadi Z; Leung HHL; Wong R; Yan F; Perdomo JS; Chong BH
Haematologica; 2022 Sep; 107(9):2195-2205. PubMed ID: 35199503
[TBL] [Abstract][Full Text] [Related]
9. Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopenia.
Newland A; McDonald V
Immunotherapy; 2020 Dec; 12(18):1325-1340. PubMed ID: 33023353
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
[TBL] [Abstract][Full Text] [Related]
11. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP.
Weitz IC; Liebman HA
Br J Haematol; 2023 Oct; 203(1):96-100. PubMed ID: 37735550
[TBL] [Abstract][Full Text] [Related]
12. CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia.
Qiu J; Liu X; Li X; Zhang X; Han P; Zhou H; Shao L; Hou Y; Min Y; Kong Z; Wang Y; Wei Y; Liu X; Ni H; Peng J; Hou M
Sci Rep; 2016 Jun; 6():27445. PubMed ID: 27321376
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine.
Aharoni M; Leader A; Shochat T; Raanani P; Spectre G
Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172
[TBL] [Abstract][Full Text] [Related]
15. Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia: studies in mouse models.
Martínez-Botía P; Meinders M; De Cuyper IM; Eble JA; Semple JW; Gutiérrez L
Blood Adv; 2022 Jun; 6(11):3529-3534. PubMed ID: 35298626
[TBL] [Abstract][Full Text] [Related]
16. Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View.
González-López TJ; Newland A; Provan D
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109773
[TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
18. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
Kaicker S; Martinko K; Bussel JB
Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
[TBL] [Abstract][Full Text] [Related]
19. The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.
Fu H; Cai X; Cui L; Nong W; Li W; Mei H; Yang T; Yue H; Huang Q; An Z; Wu Y; Huang X; Zhang X;
Ann Hematol; 2024 May; 103(5):1549-1559. PubMed ID: 38526649
[TBL] [Abstract][Full Text] [Related]
20. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience.
Chou SC; Chang YC; Liao CK; Chen TC; Sun KJ; Huang WH; Wu YF
Platelets; 2022 May; 33(4):531-535. PubMed ID: 35196955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
